Published in J Surg Res on August 15, 2008
Gender-dependent differential phosphorylation in the ERK signaling pathway is associated with increased MMP2 activity in rat aortic smooth muscle cells. J Surg Res (2009) 0.94
Dietary phytoestrogens inhibit experimental aneurysm formation in male mice. J Surg Res (2013) 0.83
Phosphorylation of AKT and abdominal aortic aneurysm formation. Am J Pathol (2014) 0.79
Mesenchymal stem cell-conditioned media suppresses inflammation-associated overproliferation of pulmonary artery smooth muscle cells in a rat model of pulmonary hypertension. Exp Ther Med (2015) 0.76
Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest (2002) 4.79
Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation (2005) 2.67
Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol (1998) 1.90
Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg (2003) 1.74
Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2004) 1.51
Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers. Br J Haematol (2004) 1.48
L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation (2005) 1.44
Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation (2001) 1.43
Gender differences in abdominal aortic aneurysm prevalence, treatment, and outcome. J Vasc Surg (1997) 1.09
Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. J Vasc Surg (2000) 1.05
Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg (1996) 1.01
Cytokine pattern in aneurysmal and occlusive disease of the aorta. J Surg Res (2001) 1.00
Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall. Br J Surg (2000) 0.97
Early MT-1 MMP expression following elastase exposure is associated with increased cleaved MMP-2 activity in experimental rodent aortic aneurysms. Surgery (2004) 0.97
Modulation of cardiac mast cell-mediated extracellular matrix degradation by estrogen. Am J Physiol Heart Circ Physiol (2005) 0.95
Genotype-phenotype relationships in an investigation of the role of proteases in abdominal aortic aneurysm expansion. Br J Surg (2005) 0.93
Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection. Surg Today (2004) 0.93
A confederacy of proteinases. J Clin Invest (2002) 0.93
The effect of purified compared with nonpurified diet on bone changes induced by hindlimb suspension of female rats. Exp Biol Med (Maywood) (2005) 0.90
Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2005) 0.83
Estrogen has opposing effects on vascular reactivity in obese, insulin-resistant male Zucker rats. J Appl Physiol (1985) (2002) 0.82
Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease. Br J Surg (1999) 0.80
Abdominal aortic aneurysms. Semin Vasc Surg (1995) 0.79
Pre-operative oestradiol levels - relation to survival in breast cancer. Eur J Surg Oncol (2001) 0.78
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2011) 2.71
Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation (2005) 2.67
Computerized microfluidic cell culture using elastomeric channels and Braille displays. Proc Natl Acad Sci U S A (2004) 2.51
The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J Vasc Surg (2009) 2.51
SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary. J Vasc Surg (2009) 2.16
Renal sonography with Doppler for detecting suspected pediatric renin-mediated hypertension - is it adequate? Pediatr Radiol (2013) 2.04
Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg (2013) 1.95
Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol (2008) 1.93
National trends in the use and outcomes of hepatic resection. J Am Coll Surg (2004) 1.92
Surgeon volume as an indicator of outcomes after carotid endarterectomy: an effect independent of specialty practice and hospital volume. J Am Coll Surg (2002) 1.91
Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation (2010) 1.84
Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg (2005) 1.76
Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg (2003) 1.74
Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg (2003) 1.74
Differential regulation of aortic growth in male and female rodents is associated with AAA development. J Surg Res (2008) 1.72
Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J (2008) 1.71
Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation (2006) 1.66
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: hospital and surgeon volume-related outcomes. J Vasc Surg (2003) 1.63
Hospital teaching status and outcomes of complex surgical procedures in the United States. Arch Surg (2004) 1.59
A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg (2010) 1.59
The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery (2003) 1.59
The association of body mass index to postoperative outcomes in elderly vascular surgery patients: a reverse J-curve phenomenon. Anesth Analg (2010) 1.57
Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery. Ann Surg (2012) 1.55
Endovascular aortic aneurysm repair with carbon dioxide-guided angiography in patients with renal insufficiency. J Vasc Surg (2012) 1.53
Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2004) 1.51
Proteomics of microparticles after deep venous thrombosis. Thromb Res (2010) 1.50
Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol (2004) 1.49
The Michigan Surgical Quality Collaborative: a legacy of Shukri Khuri. Am J Surg (2009) 1.48
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg (2007) 1.47
Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg (2006) 1.47
Changes in the utilization of spinal fusion in the United States. Neurosurgery (2006) 1.46
Outcomes after cerebral aneurysm clip occlusion in the United States: the need for evidence-based hospital referral. J Neurosurg (2003) 1.46
Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol (2012) 1.46
L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation (2005) 1.44
Variation in postoperative complication rates after high-risk surgery in the United States. Surgery (2003) 1.42
Tissue loss, early primary graft occlusion, female gender, and a prohibitive failure rate of secondary infrainguinal arterial reconstruction. J Vasc Surg (2002) 1.39
Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. J Vasc Surg (2002) 1.39
Attending, house officer, and medical student perceptions about teaching in the third-year medical school general surgery clerkship. J Am Coll Surg (2004) 1.39
Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg (2002) 1.37
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.36
A true aneurysm of the profunda femoris artery: a case report and review of the English language literature. Ann Vasc Surg (2004) 1.34
Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg (2005) 1.34
Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model. J Immunol (2006) 1.30
Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg (2005) 1.30
A negative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol (2005) 1.29
A population-based analysis of endovascular versus open thoracic aortic aneurysm repair. J Vasc Surg (2009) 1.27
Surgeon specialty and provider volumes are related to outcome of intact abdominal aortic aneurysm repair in the United States. J Vasc Surg (2003) 1.27
Hospital volume and surgical outcomes for elderly patients with colorectal cancer in the United States. J Surg Res (2003) 1.26
Who performs endocrine operations in the United States? Surgery (2003) 1.25
Measuring surgical quality: what's the role of provider volume? World J Surg (2005) 1.24
Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2013) 1.23
The impact of adjusting for reliability on hospital quality rankings in vascular surgery. J Vasc Surg (2010) 1.23
Racial disparities in the use of revascularization before leg amputation in Medicare patients. J Vasc Surg (2011) 1.22
Female gender attenuates cytokine and chemokine expression and leukocyte recruitment in experimental rodent abdominal aortic aneurysms. Ann N Y Acad Sci (2006) 1.22
National trends in outcomes for esophageal resection. Ann Thorac Surg (2005) 1.21
Variation in the use of lower extremity vascular procedures for critical limb ischemia. Circ Cardiovasc Qual Outcomes (2011) 1.20
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). Vasc Med (2011) 1.19
A contemporary analysis of outcomes for operative repair of type A aortic dissection in the United States. Surgery (2007) 1.17
Payer status is related to differences in access and outcomes of abdominal aortic aneurysm repair in the United States. Surgery (2003) 1.17
D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost (2005) 1.17
Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution. Arterioscler Thromb Vasc Biol (2010) 1.16
Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation. J Surg Res (2006) 1.15
Hybrid debranching with endovascular repair for thoracoabdominal aneurysms: a comparison with open repair. Ann Thorac Surg (2010) 1.15